Resources

This fact sheet is for current and future patients with Fabry disease explaining how a treatment for this condition, migalastat (Galafold®), will be transitioning from the Life Saving Drugs Program to the PBS. It provides further clarity on future access arrangements via the PBS.

This fact sheet is for current prescribers (treating physicians) with patients requiring treatment for Fabry disease. It explains how a treatment for this condition, migalastat (Galafold®), will be transitioning from the Life Saving Drugs Program to the PBS.

This fact sheet provides a table of frequently claimed items based on 1 July 2024 Medical Benefit Schedule (MBS).

This fact sheet provides information about the incentive, payment eligibility, servicing requirements and more.

This booklet is designed to be distributed to residential aged care residents who are interested in learning more about the incentive.

This template can be used as a care planner for aged care home residents registered as incentive patients.

This tool is for a register of a practice’s patients and participating in the incentive, to tracking their servicing requirements.

This template is for the provider and practice to track a patient’s incentive servicing requirements over the 12-month period.

This information kit is for residential aged care home staff to assist in understanding, communicating, and supporting the incentive.

This information kit targets the relevant primary care peak bodies to assist in understanding, communicating, and supporting the incentive.

This fact sheet stating the benefits of the incentive to general practitioners, residential aged care homes and residents.

This fact sheet states the principles of person-centred care, and strategies to strengthen this care under the incentive.

This fact sheet notes the key implementation partners for the incentive and their roles.

This document covers 2 hypothetical scenarios of two different people living in residential aged care homes and how the incentive can be applied in their context.

This is the government response to the final report of an independent evaluation of the Better Access to Psychiatrists, Psychologists and General Practitioners through the Medicare Benefits Schedule initiative (Better Access).

Health Ministers met today in Sydney and discussed ongoing management of shortages of IV fluids.

This statement from Australian Health Ministers provides key context for the analysis of unmet need for psychosocial supports outside of the National Disability Insurance Scheme, key findings and limitations and next steps for governments’ considerations.